Expanded Indication for Boston Materials The U.S. Food and Drug Administration has granted Bausch + Lomb 510(k) clearance for the therapeutic use of its Boston XO and Boston XO2 gas permeable contact lens materials. The expanded indication enables you to use scleral lenses manufactured with the Boston XO and Boston XO2 materials in the treatment of such conditions as dry eye disease, limbal stem cell deficiencies, skin disorders with ocular surface manifestations, neurotrophic keratitis and corneal exposure (pictured). For information, call 800.828.9030, or go to Bausch.com.
Epithelial Mapping for Diagnosing Corneal Disease Optovue has received clearance from the FDA for its epithelial thickness mapping software, or epi-mapping, a non-contact method that lets you obtain epithelial and stromal measurements for the diagnosis and management of ocular diseases. Optovue says epi-mapping can also help you determine whether patients are suitable for refractive procedures and monitor healing after refractive and corneal surgery. Epi-mapping is commercially available on the iVue and iFusion optical coherence tomography systems. For information, call 866.344.8948, or go to Optovue.com.
A Phone App for Multilingual Exams Dmitriy Richer, an optometry student at NECO, New England College of Optometry, and classmates have developed OpTranslate, a mobile app to help you conduct eye exams on non-English-speaking patients. It features the full, comprehensive eye exam split into six sections; additional sections for contact lens exams, binocular vision testing and pre-written diagnoses; and written explanations, patient education resources and labeled diagrams. Available languages include Spanish, French, Portuguese and Haitian Creole languages, with a Mandarin update planned for October and Russian, Hindi, Korean and Vietnamese updates in development. You can find OpTranslate on the App Store and Google Play. For information, go to OpTranslate.com.